Dexamethasone inhibits KSHV-induced inflammation and tumorigenesis through glucocorticoid receptor signaling.

https://pubmed.ncbi.nlm.nih.gov/38117084

Dexamethasone, a common anti-inflammatory agent, inhibits Kaposi’s sarcoma-associated herpesvirus (KSHV)-induced inflammation and tumorigenesis by activating glucocorticoid receptor signaling to suppress IL-1α and induce IL-1Ra.